The emergence of Clade IIb and Ib mpox viruses: a state-of-the-art review
Authors:
- Toufik Abdul-RahmanTAToufik Abdul-Rahman
- Jann Ludwig Mueller-GomezJMJann Ludwig Mueller-Gomez
- Hala Ibrahim ThaalibiHTHala Ibrahim Thaalibi
- Innocent AyesigaIAInnocent Ayesiga
- Oyinbolaji Akinwande AjetunmobiOyinbolaji Akinwande Ajetunmobi
- Aderinto NicholasANAderinto Nicholas
- Godfred Yawson ScottGSGodfred Yawson Scott
- Lukman LawalLLLukman Lawal
- Muritala Adewale LawalMLMuritala Adewale Lawal
- Selimat IbrahimSISelimat Ibrahim
Open Access
- 11 December 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1495-1510
Abstract
Mpox, a zoonotic Orthopoxvirus infection, was historically endemic to West and Central Africa. In 2022, it sparked a significant global outbreak, raising concerns about its spread beyond traditional regions. Notably, the emergence of Clade IIb and Ib strains has alarmed the global health community due to their increased transmission among humans. This paper examines mpox viruses and their general characteristics, their evolution, and the emergence of novel clades with unique features. Clade IIb stands out for its unique genetic mutations, which may enhance its transmissibility. Clinically, infections often present with fewer anogenital lesions and milder symptoms, which can complicate diagnosis. PCR testing remains the most reliable diagnostic tool, although emerging point-of-care tests show promise. Treatments such as tecovirimat and immune-based therapies (e.g., VIGIV) have demonstrated success, despite limitations. The MVA vaccine provides partial protection, although its efficacy against Clade IIb requires further validation. The emergence of Clades IIb and Ib, with distinct transmission dynamics, especially among specific population groups, underscores the need for targeted public health responses. This review highlights critical surveillance challenges in endemic African regions, where underreporting and limited diagnostic infrastructure hinder early detection. By analyzing the evolution and spread of newer clades, this review provides unique insights into mpox’s shifting epidemiology and outlines implications for global preparedness, including the urgent need for strengthened surveillance systems, equitable access to vaccines, and coordinated international efforts focusing on research and preparedness to help mitigate future risks.Keywords
This publication has 109 references indexed in Scilit:
- Analytical and clinical evaluation of a novel real-time PCR-based detection kit for Mpox virusMedical Microbiology and Immunology, 2024
- Poxvirus Vaccines: Past, Present, and Future2024
- Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levelsJournal of Medical Virology, 2023
- Sub‐lineage B.1.6 of hMPXV in a global context: Phylogeny and epidemiologyJournal of Medical Virology, 2023
- Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for DermatologistsAmerican Journal of Clinical Dermatology, 2023
- Clinical manifestations of human Mpox infection: A systematic review and meta‐analysisReviews in Medical Virology, 2023
- Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta‐analysisJournal of Medical Virology, 2023
- Human monkeypox (hMPXV) re‐emergence: Host immunity status and current vaccines landscapeJournal of Medical Virology, 2022
- Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way ForwardIndian Pediatrics, 2022
- The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese patients with osteoporosis: interim reportJournal of Bone and Mineral Metabolism, 2016